Slotnik Capital, LLC: APOGEE THERAPEUTICS INC (APGE): Quarterly 13F Position History
As of Q2 2026, Slotnik Capital, LLC reported 260,740 shares of APOGEE THERAPEUTICS INC (APGE), worth $34.6M and representing 9.6% of its 13F equity book. The position first appeared in Q2 2026 and has been disclosed across 1 13F-HR filing in Pactolio's tracked window.
- 260,740Shares Held (Latest Filing)
- $34.6MReported Market Value (Latest Filing)
- 9.6%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- $0Quarter-over-Quarter Value Change
- 260,740Peak Reported Shares (Historical)
Recent initiation: Slotnik Capital, LLC first reported APGE on the Q2 2026 filing, so fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 1 quarter
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 260,740 | – | – | $34.6M | 9.6% | $132.7 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Slotnik Capital, LLC first disclose a APGE position in 13F-HR filings?
Slotnik Capital, LLC first reported APOGEE THERAPEUTICS INC (APGE) on its 13F-HR filing for the period ending 2026-06-30 (Q2 2026). The position has appeared on 1 reported quarter within Pactolio's tracked window.
What was Slotnik Capital, LLC's most recent quarter-over-quarter share-count change in APGE?
Slotnik Capital, LLC reported 260,740 shares of APGE on the most recent 13F-HR filing (Q2 2026). Insufficient prior data for a quarter-over-quarter share-count comparison.
Does the implied price-per-share represent Slotnik Capital, LLC's cost basis in APGE?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.